Search Blog
Categories
November 2013
M T W T F S S
« Oct   Dec »
 123
45678910
11121314151617
18192021222324
252627282930  

Tags

Early Morning Buzz: Groupon, Gilead Sciences, Eltek Ltd, Alcatel Lucent SA

admin

By PrimeTimeMedia LLC New York, November 27, 2013 /Accesswire/ – Market Buzz Report, a leading penny stock newsletters provider, issues major news alert for Groupon, Inc. (NASDAQ: GRPN), Gilead Sciences, Inc.(NASDAQ:GILD), Eltek Ltd.(NASDAQ:ELTK), Alcatel Lucent SA (ADR)(NYSE:ALU).

There are gimmicks and then there are gimmicks. Groupon,
Inc. (NASDAQ: GRPN) is out with its gimmick for Black Friday. It sounds huge on
the headline of $100 million, yet as you might have suspected it is something a
bit smaller when you consider it. Groupon says that its Black Friday promotion
will be its largest ever promotion. The aim is to put $100 million in Groupon
Bucks in the hands of tens of millions of subscribers on Black Friday.

Free Urgent Insider Catalyst Report For GRPN Available Here: http://marketbuzzreport.com/index.php?code=GRPN (Or Copy and paste the URL into your browser)

$100 million sounds like a lot on the surface. It is meant to sound that way. The problem is that the numbers become very small when you look at this on an individual consumer level if it is really tens of millions of customers. Of course, the devil is in the details.

Shares of Gilead Sciences, Inc.(NASDAQ:GILD) hit a 52-week high of $75.21 on Nov 22, 2013 buoyed by the positive opinion of the European Medicines Agency’s (:EMA) Committee for Medicinal Products for Human Use (CHMP) on the company’s hepatitis C virus (:HCV) candidate sofosbuvir (proposed trade name: Sovaldi) 400mg once daily tablets.

Free Urgent Insider Catalyst Report For GILD Available Here: http://marketbuzzreport.com/index.php?code=GILD (Or Copy and paste the URL into your browser)

The CHMP recommended the approval of Sovaldi as a combination therapy for treating HCV patients. The positive opinion by the CHMP will be reviewed by the European Commission, which will issue the final opinion on whether to approve the HCV candidate in the EU.

Eltek Ltd.(NASDAQ:ELTK) shares rocket 57.8% pre-market following the company’s Q3 report. Although revenue climbed 2.4% Y/Y to $12.8M, EPS jumped to $0.12 from $0.02 in Q3 2012, a result of a 2.2% jump in gross margin to 18.3%.The EPS figure does not include a 3.5M share investment by Nistec in Nov., which represents 53% of shares outstanding as of Sept. 30.

Free Urgent Insider Catalyst Report For ELTK Available Here: http://marketbuzzreport.com/index.php?code=ELTK (Or Copy and paste the URL into your browser) 

Alcatel Lucent SA (ADR)(NYSE:ALU) and the Las Vegas Metro Police Department, along with the Nevada Department of Transportation and other first responders, conducted a six-month trial of a 4G LTE public safety network in a designated section of the city of Las Vegas in the United States. The trial used spectrum allocated to the First Responders Network Authority (FirstNet), an independent authority set up by the United States government to facilitate the building of a nationwide interoperable public safety broadband network.

Free Urgent Insider Catalyst Report For ALU Available Here: http://marketbuzzreport.com/index.php?code=ALU (Or Copy and paste the URL into your browser) 

USMarketBuzz.com is an investment community that focuses on MicroCap Securities. USMarketBuzz.com is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/ for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.USMarketBuzz.com/.

Follow us on Facebook: https://www.facebook.com/usmarket.buzz

Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126. (SMS alerts are free, however data rates may apply, check your wireless plan for details.)